Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia.
Intern Med J
; 53(4): 619-624, 2023 04.
Article
in English
| MEDLINE | ID: covidwho-2272984
ABSTRACT
Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or recrudescent infection. The authors conducted an online survey among infectious diseases doctors to determine current approaches to treatment across Australasia. There was marked variability in responses relating to the diagnostic modalities and use of antiviral agents in patients with immunocompromise, highlighting the need for high-quality studies to guide treatment decisions in this group.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Observational study
/
Qualitative research
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Oceania
Language:
English
Journal:
Intern Med J
Journal subject:
Internal Medicine
Year:
2023
Document Type:
Article
Affiliation country:
Imj.16064
Similar
MEDLINE
...
LILACS
LIS